Jan 10, 2022 / 08:45PM GMT
Lisa Christine Gill - JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst
Good afternoon. My name is Lisa Gill, and I'm the health care services analyst here with JPMorgan. It is with great pleasure that we have Humana with us this afternoon.
With us, we have Bruce Broussard, CEO; as well as Susan Diamond, CFO, who will join us for the breakout session after Bruce makes a couple of opening comments. Bruce, welcome, and I'll hand it off to you.
Bruce Dale Broussard - Humana Inc. - President, CEO & Director
Thanks, Lisa, and it's great being here, and thanks for including us in your conference. I would like to begin with the discussion of our 8-K and then -- that we filed last week and some clarifying comments, especially as we consider the webcast last week. A lot of the comments we made, I didn't fully -- the intentions of those comments didn't fully come alive in the -- from our investor point of view. So I want to spend a few minutes there.
And
Humana Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers